Trials / Unknown
UnknownNCT05233657
A Safety，Tolerability and Pharmacokinetics Clinical Trial of JX11502MA Capsule
An Evaluation of Safety, Tolerability and Pharmacokinetics of Single Oral Dose of JX11502MA Capsule on Healthy Human: A Phase Ia, Single Center, Randomized Clinical Trial
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 58 (estimated)
- Sponsor
- Zhejiang Jingxin Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate the safety, tolerability and pharmacokinetic characteristics of JX11502MA capsule on healthy human, and to explore the relationship between the dose, pharmacokinetic parameters and safety of JX11502MA capsule，so as to provide basis for the follow-up clinical trials (multi-dose tolerability, pharmacokinetics and phase II trial, etc.).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | JX11502MA | Oral capsule |
| DRUG | Placebo | Oral capsule |
Timeline
- Start date
- 2020-01-04
- Primary completion
- 2022-01-31
- Completion
- 2022-02-28
- First posted
- 2022-02-10
- Last updated
- 2022-02-10
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05233657. Inclusion in this directory is not an endorsement.